Share this:

Biotech Raises More Cash in 2003 But Europe Weak
The global biotechnology industry raised more money by the end of September than in the whole of 2002 but a revival in Europe, which remains weak, could be more than six months away, industry analysts said on Tuesday.

Share this:

It Lives for 29 Years?
A lawsuit filed April 11 in the U.S. District Court in Los Angeles has grabbed the attention of the life sciences community. The key parties are three high-profile biotech developers: MedImmune, Genentech and Celltech. MedImmune is challenging the validity and enforceability of an important Genentech patent. Behind that patent, MedImmune charges, is an illegal, anti-competitive agreement that ‘profoundly and fundamentally altered the competitive landscape in the biotechnology industry.’